Status:
COMPLETED
Early CPAP in COVID-19 Patients With Respiratory Failure. A Prospective Cohort Study.
Lead Sponsor:
Mario Negri Institute for Pharmacological Research
Conditions:
Early CPAP Ventilation in COVID-19 Patients
Eligibility:
All Genders
18+ years
Brief Summary
This cohort study aims at prospectively collecting detailed clinical information on patients positive to or suspected of COVID-19 visiting Italian emergency departments (EDs). The objectives of the st...
Detailed Description
All the ED patients positive to or suspected of COVID-19 infection will be included in the study. Descriptive reports of the collected data will be produced regularly. Different levels of aggregation ...
Eligibility Criteria
Inclusion
- All the ED patients positive to or suspected of COVID-19 infection with at least one of the following symptoms:
- fever
- cough/dyspnea
- SpO2 \< 95% in ambient air (\< 91% if BPCO patient).
- positive Quick Walk Test
- respiratory symptoms or admission in ED for respiratory reason
Exclusion
- age \< 18 years
- intubated patients or patients discharged in ICU in 1 hour from ED arrival
- denied consent
Key Trial Info
Start Date :
June 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 15 2022
Estimated Enrollment :
6000 Patients enrolled
Trial Details
Trial ID
NCT04323878
Start Date
June 1 2020
End Date
December 15 2022
Last Update
December 19 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Milan, Italy, 20122